Find clinical trials for Triple Negative Breast Cancer in Hanyang, Seoul

of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...

for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...

vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...

The GLORIA study is a Phase III, randomized, open-label study to prospectively evaluate the efficacy and safety of adagloxad simolenin (OBI 822)/OBI-...

with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who car...